GYRE THERAPEUTICS, INC. (GYRE) › EPS (Basic)GYRE THERAPEUTICS, INC. (GYRE) — EPS (Basic)Annual figures by period end, from SEC filings.2009-12-31: $-1.542010-12-31: $0.382011-12-31: $-0.272012-12-31: $-0.212021-12-31: $-2.872022-12-31: $0.042023-12-31: $-1.412024-12-31: $0.142025-12-31: $0.06$0.062009-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$0.06-57.1%2026-03-13From 2025-01-012024-12-31$0.14—2026-03-13From 2024-01-012023-12-31$-1.41-3625.0%2025-03-17From 2023-01-012022-12-31$0.04—2024-03-27From 2022-01-012021-12-31$-2.87—2023-03-30From 2021-01-012012-12-31$-0.21—2013-03-15From 2012-01-012011-12-31$-0.27-171.1%2013-03-15From 2011-01-012010-12-31$0.38—2013-03-15From 2010-01-012009-12-31$-1.54—2012-03-06From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares